FreeAir

PopularMy Searches

Back

List View

Most Popular

Programs

Home performance experts Grace and Corbett Lunsford utilize cutting edge diagnostic testing and methods to help solve mysterious issues in homes of all ages across America. Explore the science of homes with us. You will be glad you did. Home Diagnosis
Almost 50% of patients diagnosed with NSCLC already have stage 4 disease, and in those with stage 4 disease, only 2% will be alive in one year. After basic diagnostic testing, each patient needs to be tested for genetic alterations such as EGFR, K-RAS, EML4-ALK, and BRAF. Targeting these specific alterations allows NSCLC to be treated as multiple disease entities that can be individually managed with specific agents. Novel agents targeting specific pathways associated with apoptosis, cell proliferation, angiogenesis, and other mechanisms have emerged as a separate and unique therapeutic class delivering promising results in a vast number of malignancies. Clinicians need to know the evidence for targeted therapies—how they may improve outcomes and possibly reduce overall side effect burden. Faculty in this case-based symposium will translate the latest evidence on gene alterations and emerging management strategies to improve individualized treatments and optimize outcomes of patients with NSCLC. CME Outfitters - Individualizing Treatments for Thoracic Malignancies

Media:English Navigation:English

Earn Cash | Publish | Advertise | Device Partners | Contact Us | DMCA | Help | About FreeAir

Copyright © 2023 FreeAir.tv, Inc. ® All rights reserved.

Use of this Web site constitutes acceptance of the Terms of Use, Cloud TV Terms and Conditions, FreeAir.tv Agreements, FreeAir.tv Internet Agreements, Purchase Agreement and Privacy Policy

2.062823.live.2